Skip to main navigation Skip to search Skip to main content

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsetib in Subjects with Compensated Cirrhosis due to Nonalcoholoic Steatohepatitis (NASH) GS-US-384-1944

Project: Research

Project Details

StatusFinished
Effective start/end date06/26/17 → 02/26/24

Funding

  • Gilead Sciences Incorporated: $117,126.00